Adamed across the globe
A consistently implemented development strategy based on two pillars – innovation and international expansion – has made the pharmaceutical and biotechnology company Adamed a renowned global brand.
The international expansion of our company is based on two business models
available around the world
on a global scale
Investments in Asia
Since 2017, Adamed has been the owner of one of the most rapidly growing Vietnamese pharmaceutical companies – Davipharm. The acquisition agreement was signed in Hanoi in the presence of the President of Poland, Andrzej Duda, and the President of Vietnam, TrầnĐại Quang.
The acquisition of a controlling interest in the company constitutes the biggest Polish direct investment in Vietnam and has provided Adamed with a platform for further dynamic expansion in the Asia-Pacific region.
In 2019, Adamed purchased a block of shares in the Italian company Ecupharma. We formed a strategic partnership with the company to support Adamed’s expansion in the Italian market of cardiac medications, and ultimately also in otherareas of therapy.
Ecupharma is a rapidly growing pharmaceutical company active in the fields of neuropsychiatry and urology. Its product portfolio addresses the needs of people with chronic ailments. The company consistently builds its market standing with the support of its loyal customers. Similarly to Adamed, the company also focuses on health conditions affecting the elderly, seeking to respond to contemporary demographic challenges.